VANCOUVER, British Columbia, October 21, 2011 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued Equity Research for top traded penny stocks: Hudson City Bancorp (NASDAQ:HCBK), Boston Scientific (NYSE:BSX), Neoprobe (AMEX:NEOP). More reports for Atmel (NASDAQ:ATML), YRC Worldwide (NASDAQ:YRCW) & Dendreon (NASDAQ:DNDN).
Many investors like to invest in good penny stocks, but it is hard to find a penny stock that may double its stock price in a week as there is over 9,000 penny stocks listed in the exchanges. It is easier to start searching penny stocks with huge insider trades in the past few weeks.
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Research Report Highlights:
Hudson City Bancorp, Inc. (NASDAQ:HCBK): Quarter Report Coming
Insider Trade Signals: Hudson City Bancorp, Inc. (NASDAQ: HCBK), the holding company for Hudson City Savings Bank, will report the results of operations for the quarter ended September 30, 2011 on Wednesday, October 26, 2011. Want to know when insiders start selling? Get an email alert for the latest insider buying/selling by subscribing for free below.
Read Full Report: http://www.Pennystocksinsiders.com/PR/102111A/HCBK/HudsonCityBancorp.pdf
Boston Scientific Corporation (NYSE:BSX): Stock Price Dropped in Spite of Good News
Insider Trade Signals: Boston Scientific Corporation (NYSE: BSX) announces financial results for the third quarter ended September 30, 2011, as well as updated sales and earnings per share (EPS) guidance for the fourth quarter and full year 2011. Boston Scientific exceeds third quarter EPS guidance and repurchases 30 million shares. Want to track the insiders' trading activities moving forward?
Read Full Report: http://www.Pennystocksinsiders.com/PR/102111A/BSX/BostonScientific.pdf
Neoprobe Corporation (AMEX:NEOP): Insider Trading Before Quarterly Earnings Release
Insider Trade Signals: Neoprobe Corporation (AMEX:NEOP) today announced that its New Drug Application (NDA) for Lymphoseek has been accepted for review by the U.S. Food and Drug Administration. But PSI found company director sold his shares on Oct 17. Want to monitor this company on an on-going basis? It can be done for free by registering below.
Read Full Report: http://www.Pennystocksinsiders.com/PR/102111A/NEOP/Neoprobe.pdf
Today Pennystocksinsiders.com also released other research reports for:
Atmel Corporation (NASDAQ:ATML)
Read Full Report: http://www.Pennystocksinsiders.com/PR/102111A/ATML/Atmel.pdf
YRC Worldwide Inc. (NASDAQ:YRCW)
Read Full Report: http://www.Pennystocksinsiders.com/PR/102111A/YRCW/YRCWorldwide.pdf
Dendreon Corporation (NASDAQ:DNDN)
Read Full Report: http://www.Pennystocksinsiders.com/PR/102111A/DNDN/Dendreon.pdf
More Individual Stock Reports & Sector Reports:
http://www.Pennystocksinsiders.com/mediaroom/
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
About Pennystocksinsiders.com:
Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Important Disclaimer:
Please visit http://www.Pennystocksinsiders.com/disclaimers/index.php for details.
